These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. [GEOS (Gabitril Epilepsy Observational Study) -- Polish results of the international study of tiagabine in partial epilepsy]. Niedzielska K Neurol Neurochir Pol; 2005; 39(6):459-65. PubMed ID: 16355303 [TBL] [Abstract][Full Text] [Related]
12. Tiagabine for complex partial seizures: a randomized, add-on, dose-response trial. Uthman BM; Rowan AJ; Ahmann PA; Leppik IE; Schachter SC; Sommerville KW; Shu V Arch Neurol; 1998 Jan; 55(1):56-62. PubMed ID: 9443711 [TBL] [Abstract][Full Text] [Related]
13. Tiagabine therapy for complex partial seizures. A dose-frequency study. The Tiagabine Study Group. Sachdeo RC; Leroy RF; Krauss GL; Drake ME; Green PM; Leppik IE; Shu VS; Ringham GL; Sommerville KW Arch Neurol; 1997 May; 54(5):595-601. PubMed ID: 9152116 [TBL] [Abstract][Full Text] [Related]
14. Effects of tiagabine monotherapy on abilities, adjustment, and mood. Dodrill CB; Arnett JL; Shu V; Pixton GC; Lenz GT; Sommerville KW Epilepsia; 1998 Jan; 39(1):33-42. PubMed ID: 9578010 [TBL] [Abstract][Full Text] [Related]
15. GABI-balance--a non-interventional observational study on the effectiveness of tiagabine in add-on therapy in partial epilepsy. Chmielewska B; Stelmasiak Z Neurol Neurochir Pol; 2008; 42(4):303-11. PubMed ID: 18975234 [TBL] [Abstract][Full Text] [Related]
16. New antiepileptic drugs: comparison of key clinical trials. Cramer JA; Fisher R; Ben-Menachem E; French J; Mattson RH Epilepsia; 1999 May; 40(5):590-600. PubMed ID: 10386528 [TBL] [Abstract][Full Text] [Related]
17. A review of the antiepileptic drug tiagabine. Schachter SC Clin Neuropharmacol; 1999; 22(6):312-7. PubMed ID: 10626090 [TBL] [Abstract][Full Text] [Related]
18. Transient dystonias in three patients treated with tiagabine. Wolańczyk T; Grabowska-Grzyb A Epilepsia; 2001 Jul; 42(7):944-6. PubMed ID: 11488897 [TBL] [Abstract][Full Text] [Related]
19. A double-blind, placebo-controlled trial of tiagabine given three-times daily as add-on therapy for refractory partial seizures. Northern European Tiagabine Study Group. Kälviäinen R; Brodie MJ; Duncan J; Chadwick D; Edwards D; Lyby K Epilepsy Res; 1998 Mar; 30(1):31-40. PubMed ID: 9551842 [TBL] [Abstract][Full Text] [Related]